FMII
ENTA icon

Farmers & Merchants Investments Inc’s Enanta Pharmaceuticals ENTA Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-15
Closed -$321 – 1773
2023
Q2 		$321 Hold
15
– – ﹤0.01% 1672
2023
Q1 		$607 Hold
15
– – ﹤0.01% 1539
2022
Q4 		$698 Buy
15
+3
+25% +$137 ﹤0.01% 1515
2022
Q3 		$1K Buy
+12
New +$701 ﹤0.01% 1245

Other funds holding ENTA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Farmers & Merchants Investments Inc's ENTA Position: Q3 2023 in Review

Farmers & Merchants Investments Inc sold out of Enanta Pharmaceuticals (ENTA) in Q3 2023, closing a stake of 15 shares — an estimated $321 sold.

Farmers & Merchants Investments Inc first reported a position in ENTA in Q3 2022 and held it in 4 quarters. The position peaked at $1K in Q3 2022. 133 funds tracked by Wall St. Rank hold ENTA as of Q3 2023.

  • Farmers & Merchants Investments Inc reported no remaining Enanta Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Farmers & Merchants Investments Inc sold 15 Enanta Pharmaceuticals shares in Q3 2023, an estimated $321.
  • Farmers & Merchants Investments Inc first reported a position in Enanta Pharmaceuticals in Q3 2022 and held it in 4 quarters.
  • Farmers & Merchants Investments Inc's Enanta Pharmaceuticals position peaked at $1K in Q3 2022.
  • 133 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2023.

Based on Farmers & Merchants Investments Inc's 13F filing for Q3 2023, filed 25 Oct 2023.